文献速递临床试验与 GCP流行病学与生物统计

单中心随机对照试验:伴侣导航促进注射吸毒者丙型肝炎治疗——YETI伴侣试验研究方案

A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You're Empowered for Treatment Initiation (YETI) partner trial.
PubMed 文献 · Trials · 2025-01-22

YETI伴侣试验是一项单中心随机对照试验,旨在评估以主要注射伴侣作为同伴导航员的两阶段行为干预对丙型肝炎治疗启动的效果。计划在加利福尼亚州旧金山招募250名注射吸毒者及其主要注射伴侣,按1:1随机分为对照组和干预组。主要结局为丙型肝炎治疗启动,次要结局包括治疗完成和治疗结束后12周的持续病毒学应答。

要点

  • 单中心随机对照试验评估伴侣导航干预对丙型肝炎治疗启动的效果。
  • 计划招募250名注射吸毒者及其主要注射伴侣,按1:1随机分组。
  • 主要结局为治疗启动,次要结局包括治疗完成和治疗后12周持续病毒学应答。

核心结论

  • 该试验将为一种利用主要注射伴侣支持来启动丙型肝炎治疗的新型治疗链接干预提供证据。
  • 若干预成功,可为针对边缘化人群丙型肝炎的公共卫生策略和政策提供信息。

研究设计与样本

  • YETI伴侣试验是一项单中心随机对照试验,评估以注射伴侣作为同伴导航员的两阶段行为干预对丙型肝炎治疗的有效性。
  • 计划在加利福尼亚州旧金山招募250名注射吸毒者及其主要注射伴侣,按1:1随机分配至对照组或干预组。
  • 数据通过问卷和电子健康记录收集,采用意向性分析和混合效应模型进行分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disparities persist in testing and treatment for hepatitis C virus (HCV), leaving socially marginalized populations, including people who inject drugs (PWID), less likely to benefit from curative treatment. Linkage services are often insufficient to overcome barriers to navigating the medical system and contextual factors. METHODS: The You're Empowered for Treatment Initiation (YETI) Partner trial is a single-site randomized controlled trial evaluating the efficacy of a two-session behavioral intervention that engages injecting partners as peer navigators for HCV treatment. We aim to recruit 250 PWID and their primary injecting partners in San Francisco, California, randomizing them 1:1 to either a control or intervention group. The primary outcome is the initiation of HCV treatment, with secondary outcomes including treatment completion and sustained virologic response 12 weeks post-treatment. Data will be collected through questionnaires and electronic health records and analyzed using intention-to-treat and mixed-effects models. DISCUSSION: This trial will provide evidence of a new HCV treatment linkage intervention leveraging the support of primary injecting partners to initiate HCV treatment. If successful, the intervention could inform public health strategies and policies to address HCV in marginalized populations. TRIAL REGISTRATION: ClinicalTrials.gov NCT06179498. Registered on December 22, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Morris MD, Tan JY, McDonell CC, et al. A single-site randomized controlled trial of partner navigation to HCV treatment for people who inject drugs: a study protocol for the You're Empowered for Treatment Initiation (YETI) partner trial. Trials. 2025. PMID: 39844334. doi:10.1186/s13063-024-08662-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。